InflaRx (IFRX) Liabilities and Shareholders Equity (2022 - 2025)

InflaRx (IFRX) has disclosed Liabilities and Shareholders Equity for 4 consecutive years, with $64.3 million as the latest value for Q4 2025.

  • Quarterly Liabilities and Shareholders Equity fell 20.88% to $64.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $379.3 million through Dec 2025, changed N/A year-over-year, with the annual reading at $64.3 million for FY2025, 20.88% down from the prior year.
  • Liabilities and Shareholders Equity hit $64.3 million in Q4 2025 for InflaRx, down from $81.2 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $129.3 million in Q4 2023 to a low of $64.3 million in Q4 2025.
  • Historically, Liabilities and Shareholders Equity has averaged $94.8 million across 4 years, with a median of $92.9 million in 2022.
  • Biggest five-year swings in Liabilities and Shareholders Equity: rose 23.8% in 2023 and later plummeted 37.19% in 2024.
  • Year by year, Liabilities and Shareholders Equity stood at $104.5 million in 2022, then increased by 23.8% to $129.3 million in 2023, then tumbled by 37.19% to $81.2 million in 2024, then decreased by 20.88% to $64.3 million in 2025.
  • Business Quant data shows Liabilities and Shareholders Equity for IFRX at $64.3 million in Q4 2025, $81.2 million in Q4 2024, and $129.3 million in Q4 2023.